1. Home
  2. TVTX vs INSW Comparison

TVTX vs INSW Comparison

Compare TVTX & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • INSW
  • Stock Information
  • Founded
  • TVTX 2008
  • INSW 1999
  • Country
  • TVTX United States
  • INSW United States
  • Employees
  • TVTX N/A
  • INSW N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • INSW Semiconductors
  • Sector
  • TVTX Health Care
  • INSW Technology
  • Exchange
  • TVTX Nasdaq
  • INSW Nasdaq
  • Market Cap
  • TVTX 1.9B
  • INSW 1.7B
  • IPO Year
  • TVTX N/A
  • INSW N/A
  • Fundamental
  • Price
  • TVTX $17.92
  • INSW $33.09
  • Analyst Decision
  • TVTX Strong Buy
  • INSW Strong Buy
  • Analyst Count
  • TVTX 13
  • INSW 3
  • Target Price
  • TVTX $33.17
  • INSW $60.00
  • AVG Volume (30 Days)
  • TVTX 1.6M
  • INSW 823.2K
  • Earning Date
  • TVTX 05-05-2025
  • INSW 05-07-2025
  • Dividend Yield
  • TVTX N/A
  • INSW 15.52%
  • EPS Growth
  • TVTX N/A
  • INSW N/A
  • EPS
  • TVTX N/A
  • INSW 8.38
  • Revenue
  • TVTX $233,175,000.00
  • INSW $951,613,000.00
  • Revenue This Year
  • TVTX $72.95
  • INSW N/A
  • Revenue Next Year
  • TVTX $53.84
  • INSW $2.65
  • P/E Ratio
  • TVTX N/A
  • INSW $3.96
  • Revenue Growth
  • TVTX 60.55
  • INSW N/A
  • 52 Week Low
  • TVTX $5.12
  • INSW $31.70
  • 52 Week High
  • TVTX $25.29
  • INSW $65.94
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 36.88
  • INSW 41.01
  • Support Level
  • TVTX $20.29
  • INSW $33.56
  • Resistance Level
  • TVTX $20.98
  • INSW $34.92
  • Average True Range (ATR)
  • TVTX 0.96
  • INSW 1.10
  • MACD
  • TVTX -0.10
  • INSW 0.03
  • Stochastic Oscillator
  • TVTX 11.94
  • INSW 26.56

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About INSW International Seaways Inc.

International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.

Share on Social Networks: